118 related articles for article (PubMed ID: 24665587)
21. Serological assessment of measles-rubella vaccination catch-up campaign among university students.
Takeuchi J; Goto M; Kawamura T; Hiraide A
Pediatr Int; 2014 Jun; 56(3):395-9. PubMed ID: 24417932
[TBL] [Abstract][Full Text] [Related]
22. Waning antibody levels and avidity: implications for MMR vaccine-induced protection.
Kontio M; Jokinen S; Paunio M; Peltola H; Davidkin I
J Infect Dis; 2012 Nov; 206(10):1542-8. PubMed ID: 22966129
[TBL] [Abstract][Full Text] [Related]
23. Persistence and Half-lives of Anti-measles and Anti-rubella Antibodies in Japanese Hospital Workers: A Longitudinal Study.
Kato H; Mori M; Oba M; Kawahara H; Kaneko T
Intern Med; 2016; 55(18):2587-94. PubMed ID: 27629951
[TBL] [Abstract][Full Text] [Related]
24. [Comparison of positivity rates for antibodies against measles, rubella, chickenpox and mumps by assays].
Terada K; Niizuma T; Daimon Y; Kataoka N; Niki Y
Kansenshogaku Zasshi; 2000 Aug; 74(8):670-4. PubMed ID: 11019516
[TBL] [Abstract][Full Text] [Related]
25. [Rubella vaccination during puerperium? Effect of rubella vaccination during puerperium on the titer of HAH].
Dennin RH; Bader C; Husstedt W
Fortschr Med; 1978 Jul; 96(28):1407-10. PubMed ID: 669534
[TBL] [Abstract][Full Text] [Related]
26. A case study of measles vaccination for university students during the measles outbreak in Tokyo, Japan, 2007.
Fujisaki R; Yamamura M; Abe S; Shimogawara K; Kasahara M; Nishiya H; Makimura M; Makimura K
J Infect Chemother; 2012 Jun; 18(3):341-6. PubMed ID: 22134852
[TBL] [Abstract][Full Text] [Related]
27. [Investigation of antibodies against measles antigen in institutionalized patients with severe motor and intellectual disability].
Machida Y; Yamamoto J; Yano Y; Yano T
Kansenshogaku Zasshi; 2008 Jul; 82(4):328-34. PubMed ID: 18697485
[TBL] [Abstract][Full Text] [Related]
28. Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus.
Christenson B; Böttiger M
Vaccine; 1994 Feb; 12(2):129-33. PubMed ID: 8147093
[TBL] [Abstract][Full Text] [Related]
29. [Preliminary study on nasal spray of interferon alpha-2b used for prevention of rubella and measles virus infections].
Zhao J; Zhu FC; Shu YL; Zhou R; Liu LQ; Zhang LL; Shi ZY; Tang Z; Lin LZ; Yu ZA; Zhang LP; Zhang B; Hou YD
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Sep; 19(3):220-2. PubMed ID: 16261201
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of HI antibody titer against rubella virus to determine the effect of mass vaccination in Tehran.
Soleimanjahi H; Bamdad T; Fotouhi F; Roustai MH; Faghihzadeh S
J Clin Virol; 2005 Oct; 34(2):153-4. PubMed ID: 16076562
[TBL] [Abstract][Full Text] [Related]
31. Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohorts.
Davidkin I; Valle M
Vaccine; 1998 Dec; 16(20):2052-7. PubMed ID: 9796064
[TBL] [Abstract][Full Text] [Related]
32. Measles immunity and response to revaccination among secondary school children in Cumbria.
Calvert N; Cutts F; Irving R; Brown D; Marsh J; Miller E
Epidemiol Infect; 1996 Feb; 116(1):65-70. PubMed ID: 8626005
[TBL] [Abstract][Full Text] [Related]
33. Measles Virus Neutralizing Antibody Response, Cell-Mediated Immunity, and Immunoglobulin G Antibody Avidity Before and After Receipt of a Third Dose of Measles, Mumps, and Rubella Vaccine in Young Adults.
Fiebelkorn AP; Coleman LA; Belongia EA; Freeman SK; York D; Bi D; Kulkarni A; Audet S; Mercader S; McGrew M; Hickman CJ; Bellini WJ; Shivakoti R; Griffin DE; Beeler J
J Infect Dis; 2016 Apr; 213(7):1115-23. PubMed ID: 26597262
[TBL] [Abstract][Full Text] [Related]
34. [Measles antibody followed after measles vaccination: comparison with gelatin beads agglutination (PA) antibody, hemagglutination inhibition (HI) antibody and IgG-avidity].
Saika S; Suzuki K; Ichinohe S
Kansenshogaku Zasshi; 2003 Oct; 77(10):809-14. PubMed ID: 14608913
[TBL] [Abstract][Full Text] [Related]
35. Prospective Study of Live Attenuated Vaccines for Patients with Nephrotic Syndrome Receiving Immunosuppressive Agents.
Kamei K; Miyairi I; Ishikura K; Ogura M; Shoji K; Funaki T; Ito R; Arai K; Abe J; Kawai T; Onodera M; Ito S
J Pediatr; 2018 May; 196():217-222.e1. PubMed ID: 29499990
[TBL] [Abstract][Full Text] [Related]
36. Kinetics of antibody and memory B cell responses after MMR immunization in children and young adults.
Kakoulidou M; Ingelman-Sundberg H; Johansson E; Cagigi A; Farouk SE; Nilsson A; Johansen K
Vaccine; 2013 Jan; 31(4):711-7. PubMed ID: 23174196
[TBL] [Abstract][Full Text] [Related]
37. [Study of the antibodies against measles, rubella, mumps and varicella-zoster viruses in sera from the medical staffs].
Shiraishi T; Nakagawa M; Nakagawa Y; Tominaga M; Yoshitani S
Kansenshogaku Zasshi; 2005 May; 79(5):322-8. PubMed ID: 15977572
[TBL] [Abstract][Full Text] [Related]
38. [Accumulative vaccination rate of rubella and positive antibody rate in an area of Japan--future problems with rubella].
Terada K; Niizuma T; Daimon Y; Kataoka N
Kansenshogaku Zasshi; 1999 Oct; 73(10):1038-41. PubMed ID: 10565119
[TBL] [Abstract][Full Text] [Related]
39. Responses in children to measles vaccination associated with perirenal transplantation.
Mori K; Kawamura K; Honda M; Sasaki N
Pediatr Int; 2009 Oct; 51(5):617-20. PubMed ID: 19438829
[TBL] [Abstract][Full Text] [Related]
40. A novel cell-based high throughput assay to determine neutralizing antibody titers against circulating strains of rubella virus.
Kanbayashi D; Kurata T; Takahashi K; Kase T; Komano J
J Virol Methods; 2018 Feb; 252():86-93. PubMed ID: 29191395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
